Advertisement
UK markets closed
  • FTSE 100

    8,044.81
    +20.94 (+0.26%)
     
  • FTSE 250

    19,799.72
    +200.33 (+1.02%)
     
  • AIM

    755.74
    +6.56 (+0.88%)
     
  • GBP/EUR

    1.1623
    +0.0034 (+0.29%)
     
  • GBP/USD

    1.2432
    +0.0082 (+0.66%)
     
  • Bitcoin GBP

    53,434.43
    +312.00 (+0.59%)
     
  • CMC Crypto 200

    1,431.30
    +16.54 (+1.17%)
     
  • S&P 500

    5,059.87
    +49.27 (+0.98%)
     
  • DOW

    38,422.67
    +182.69 (+0.48%)
     
  • CRUDE OIL

    82.77
    +0.87 (+1.06%)
     
  • GOLD FUTURES

    2,334.70
    -11.70 (-0.50%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     
  • DAX

    18,137.65
    +276.85 (+1.55%)
     
  • CAC 40

    8,105.78
    +65.42 (+0.81%)
     

ECO Animal Health Group plc's (LON:EAH) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

ECO Animal Health Group (LON:EAH) has had a rough three months with its share price down 16%. But if you pay close attention, you might find that its key financial indicators look quite decent, which could mean that the stock could potentially rise in the long-term given how markets usually reward more resilient long-term fundamentals. Particularly, we will be paying attention to ECO Animal Health Group's ROE today.

ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. In other words, it is a profitability ratio which measures the rate of return on the capital provided by the company's shareholders.

Check out our latest analysis for ECO Animal Health Group

How Is ROE Calculated?

The formula for return on equity is:

ADVERTISEMENT

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

So, based on the above formula, the ROE for ECO Animal Health Group is:

17% = UK£17m ÷ UK£97m (Based on the trailing twelve months to March 2021).

The 'return' is the yearly profit. Another way to think of that is that for every £1 worth of equity, the company was able to earn £0.17 in profit.

Why Is ROE Important For Earnings Growth?

Thus far, we have learned that ROE measures how efficiently a company is generating its profits. Depending on how much of these profits the company reinvests or "retains", and how effectively it does so, we are then able to assess a company’s earnings growth potential. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don’t share these attributes.

A Side By Side comparison of ECO Animal Health Group's Earnings Growth And 17% ROE

To begin with, ECO Animal Health Group seems to have a respectable ROE. Further, the company's ROE is similar to the industry average of 19%. As you might expect, the 12% net income decline reported by ECO Animal Health Group is a bit of a surprise. Based on this, we feel that there might be other reasons which haven't been discussed so far in this article that could be hampering the company's growth. These include low earnings retention or poor allocation of capital.

So, as a next step, we compared ECO Animal Health Group's performance against the industry and were disappointed to discover that while the company has been shrinking its earnings, the industry has been growing its earnings at a rate of 6.0% in the same period.

past-earnings-growth
past-earnings-growth

Earnings growth is a huge factor in stock valuation. It’s important for an investor to know whether the market has priced in the company's expected earnings growth (or decline). This then helps them determine if the stock is placed for a bright or bleak future. One good indicator of expected earnings growth is the P/E ratio which determines the price the market is willing to pay for a stock based on its earnings prospects. So, you may want to check if ECO Animal Health Group is trading on a high P/E or a low P/E, relative to its industry.

Is ECO Animal Health Group Making Efficient Use Of Its Profits?

ECO Animal Health Group's declining earnings is not surprising given how the company is spending most of its profits in paying dividends, judging by its three-year median payout ratio of 72% (or a retention ratio of 28%). With only very little left to reinvest into the business, growth in earnings is far from likely.

Moreover, ECO Animal Health Group has been paying dividends for at least ten years or more suggesting that management must have perceived that the shareholders prefer dividends over earnings growth. Upon studying the latest analysts' consensus data, we found that the company's future payout ratio is expected to drop to 12% over the next three years. Still forecasts suggest that ECO Animal Health Group's future ROE will drop to 9.5% even though the the company's payout ratio is expected to decrease. This suggests that there could be other factors could driving the anticipated decline in the company's ROE.

Conclusion

Overall, we feel that ECO Animal Health Group certainly does have some positive factors to consider. Yet, the low earnings growth is a bit concerning, especially given that the company has a high rate of return. Investors could have benefitted from the high ROE, had the company been reinvesting more of its earnings. As discussed earlier, the company is retaining a small portion of its profits. Having said that, looking at current analyst estimates, we found that the company's earnings growth rate is expected to see a huge improvement. To know more about the latest analysts predictions for the company, check out this visualization of analyst forecasts for the company.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.